{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:34:20Z","timestamp":1791135260315,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10157-013-0847-z","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T00:49:09Z","timestamp":1377218949000},"page":"265-268","source":"Crossref","is-referenced-by-count":82,"title":["Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Nosratola D.","family":"Vaziri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"847_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000321845","volume":"31","author":"ND Vaziri","year":"2011","unstructured":"Vaziri ND, Norris K. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif. 2011;31:189\u201396.","journal-title":"Blood Purif"},{"key":"847_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms and potential consequences. Am J Physiol, Renal Physiol. 2006;290:262\u201372.","journal-title":"Am J Physiol, Renal Physiol"},{"key":"847_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","volume":"10","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND, Moradi H. Mechanism of dyslipidemia of chronic renal failure. Hemodial Int. 2006;10:1\u20137.","journal-title":"Hemodial Int"},{"issue":"1","key":"847_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.jrn.2010.10.017","volume":"21","author":"GA Kaysen","year":"2011","unstructured":"Kaysen GA. New insights into lipid metabolism in chronic kidney disease. J Ren Nutr. 2011;21(1):120\u20133.","journal-title":"J Ren Nutr"},{"key":"847_CR5","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/ndt\/13.9.2281","volume":"13","author":"I Rajman","year":"1998","unstructured":"Rajman I, Harper L, McPake D, et al. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant. 1998;13:2281\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"847_CR6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0272-6386(00)70255-1","volume":"35","author":"CJ Deighan","year":"2000","unstructured":"Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis. 2000;35:852\u201362.","journal-title":"Am J Kidney Dis"},{"key":"847_CR7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.V1051027","volume":"10","author":"F Kronenberg","year":"1999","unstructured":"Kronenberg F, Neyer U, Lhotta K, et al. The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol. 1999;10:1027\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"847_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrneph.2010.36","volume":"6","author":"ND Vaziri","year":"2010","unstructured":"Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010;6(5):287\u201396.","journal-title":"Nat Rev Nephrol"},{"key":"847_CR9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ki.1990.58","volume":"37","author":"M Akmal","year":"1990","unstructured":"Akmal M, Kasim SE, Soliman AR, Massry SG. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int. 1990;37:854\u20138.","journal-title":"Kidney Int"},{"key":"847_CR10","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/ki.1996.515","volume":"50","author":"ND Vaziri","year":"1996","unstructured":"Vaziri ND, Liang K. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 1996;50:1928\u201335.","journal-title":"Kidney Int"},{"key":"847_CR11","first-page":"F925","volume":"273","author":"ND Vaziri","year":"1997","unstructured":"Vaziri ND, Wang XQ, Liang K. Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Am J Physiol. 1997;273:F925\u201330.","journal-title":"Am J Physiol"},{"key":"847_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-011-0549-3","volume":"16","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Yuan J, Ni Z, Nicholas SB, Norris KC. Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression. Clin Exp Nephrol. 2012;16:238\u201343.","journal-title":"Clin Exp Nephrol"},{"key":"847_CR13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","volume":"108","author":"J Herz","year":"2001","unstructured":"Herz J, Strickland DK. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 2001;108:779\u201384.","journal-title":"J Clin Invest"},{"key":"847_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1523-1755.2005.00166.x","volume":"67","author":"C Kim","year":"2005","unstructured":"Kim C, Vaziri ND. Downregulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. Kidney Int. 2005;67:1028\u201332.","journal-title":"Kidney Int"},{"issue":"8","key":"847_CR15","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/ndt\/gfp120","volume":"24","author":"MV Pahl","year":"2009","unstructured":"Pahl MV, Ni Z, Sepassi L, Vaziri ND. Plasma phospholipid transfer protein, cholesterol ester transfer protein and lecithin: cholesterol acyltransferase in end-stage renal disease. Nephrol Dial Transplant. 2009;24(8):2541\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"847_CR16","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1172\/JCI118657","volume":"97","author":"M Klin","year":"1996","unstructured":"Klin M, Smogorzewski M, Ni Z, Zhang G, Massry SG. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest. 1996;97:2167\u201373.","journal-title":"J Clin Invest"},{"key":"847_CR17","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/ki.1997.263","volume":"51","author":"K Liang","year":"1997","unstructured":"Liang K, Vaziri ND. Downregulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int. 1997;51:1933\u20137.","journal-title":"Kidney Int"},{"key":"847_CR18","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1046\/j.1523-1755.2003.00281.x","volume":"64","author":"T Sato","year":"2003","unstructured":"Sato T, Liang K, Vaziri ND. Protein restriction and AST-120 improve lipoprotein lipase, hepatic lipase and VLDL receptor deficiencies in focal glomerulosclerosis. Kidney Int. 2003;64:1780\u20136.","journal-title":"Kidney Int"},{"key":"847_CR19","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1073\/pnas.89.19.9252","volume":"89","author":"S Takahashi","year":"1992","unstructured":"Takahashi S, Kawarabayasi Y, Nakai T, et al. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA. 1992;89:9252\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"847_CR20","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/ki.1997.242","volume":"51","author":"K Liang","year":"1997","unstructured":"Liang K, Vaziri ND. Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int. 1997;51:1761\u20135.","journal-title":"Kidney Int"},{"key":"847_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1523-1755.2002.00104.x","volume":"61","author":"T Sato","year":"2002","unstructured":"Sato T, Liang K. VaziriND: downregulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Kidney Int. 2002;61:157\u201362.","journal-title":"Kidney Int"},{"key":"847_CR22","unstructured":"Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol (2012) pii: S0735-1097(12)04651-7."},{"issue":"4","key":"847_CR23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.2009.177","volume":"76","author":"ND Vaziri","year":"2009","unstructured":"Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 2009;76(4):437\u201344.","journal-title":"Kidney Int"},{"key":"847_CR24","unstructured":"Moradi H, Said HM, Vaziri ND Post-transcriptional nature of uremia-induced down-regulation of hepatic apolipoprotein A-I production. Transl Res PMID: 23219399, (2012)."},{"key":"847_CR25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.hco.0000231402.87232.aa","volume":"21","author":"B Shao","year":"2006","unstructured":"Shao B, Oda MN, Oram JF, Heinecke JW. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol. 2006;21:322\u20138.","journal-title":"Curr Opin Cardiol"},{"key":"847_CR26","doi-asserted-by":"crossref","first-page":"E676","DOI":"10.1152\/ajpendo.00364.2001","volume":"283","author":"K Liang","year":"2002","unstructured":"Liang K, Vaziri ND. Upregulation of Acyl-CoA: cholesterol acyltransferase (ACAT) in chronic renal failure. Am J Physiol Endocrinol Metab. 2002;283:E676\u201381.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"847_CR27","doi-asserted-by":"crossref","first-page":"F1297","DOI":"10.1152\/ajprenal.90761.2008","volume":"296","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Moradi H, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol. 2009;296(6):F1297\u2013306.","journal-title":"Am J Physiol Renal Physiol"},{"key":"847_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000210020","volume":"30","author":"H Moradi","year":"2009","unstructured":"Moradi H, Yuan J, Ni Z, Norris K, Vaziri ND. Reverse cholesterol transport pathway in experimental chronic kidney disease. Am J Nephrol. 2009;30:147\u201354.","journal-title":"Am J Nephrol"},{"issue":"3","key":"847_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000316479","volume":"32","author":"ND Vaziri","year":"2010","unstructured":"Vaziri ND, Bai Y, Yuan J, Said H, Sigala W, Ni Z. ApoA-1 mimetic peptide reverses uremia-induced up-regulation of pro-atherogenic pathways in the aorta. Am J Nephrol. 2010;32(3):201\u201311.","journal-title":"Am J Nephrol"},{"key":"847_CR30","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1046\/j.1523-1755.2001.00734.x","volume":"59","author":"ND Vaziri","year":"2001","unstructured":"Vaziri ND, Liang K, Parks JS. Downregulation of hepatic lecithin: cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int. 2001;59:2192\u20136.","journal-title":"Kidney Int"},{"key":"847_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","volume":"421","author":"LO Martinez","year":"2003","unstructured":"Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabez\u00f3n E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terc\u00e9 F, Collet X, Perret B, Barbaras R. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature. 2003;421:75\u20139.","journal-title":"Nature"},{"key":"847_CR32","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/ajprenal.00296.2005","volume":"290","author":"G Adams","year":"2006","unstructured":"Adams G, Vaziri ND. Skeletal muscle dysfunction in chronic renal failure: effect of exercise. Am J Physiol Renal Physiol. 2006;290:783\u201391.","journal-title":"Am J Physiol Renal Physiol"},{"key":"847_CR33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","volume":"104","author":"CK Glass","year":"2001","unstructured":"Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503\u201316.","journal-title":"Cell"},{"key":"847_CR34","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1161\/01.CIR.101.25.2889","volume":"101","author":"D Li","year":"2000","unstructured":"Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101:2889\u201395.","journal-title":"Circulation"},{"key":"847_CR35","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"847_CR36","first-page":"S1","volume":"51","author":"AJ Collins","year":"2008","unstructured":"Collins AJ, Foley R, Herzog C, et al. Excerpts from the US renal data system 2007 annual data report. Am J Kidney Dis. 2008;51:S1\u2013320.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 1","key":"847_CR37","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.ASN.0000093240.84097.FE","volume":"15","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol. 2004;15(Suppl. 1):S77\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"847_CR38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneph.2010.143","volume":"6","author":"TB Dr\u00fceke","year":"2010","unstructured":"Dr\u00fceke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol. 2010;6:723\u201335.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"847_CR39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","volume":"15","author":"U Schwarz","year":"2000","unstructured":"Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15(2):218\u201323.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 11","key":"847_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_11.28","volume":"17","author":"R Pecoits-Filho","year":"2002","unstructured":"Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome\u2013\u2013the heart of the matter. Nephrol Dial Transplant. 2002;17(Suppl 11):28\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"847_CR41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.291.4.451","volume":"291","author":"Y Liu","year":"2004","unstructured":"Liu Y, Coresh J, Eustace JA, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291:451\u20139.","journal-title":"JAMA"},{"key":"847_CR42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2006070795","volume":"18","author":"RD Kilpatrick","year":"2007","unstructured":"Kilpatrick RD, McAllister CJ, Kovesdy CP, et al. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol. 2007;18:293\u2013303.","journal-title":"J Am Soc Nephrol"},{"key":"847_CR43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238\u201348.","journal-title":"N Engl J Med"},{"key":"847_CR44","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstrom","year":"2009","unstructured":"Fellstrom BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395\u2013407.","journal-title":"N Engl J Med"},{"key":"847_CR45","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomized placebo-controlled trial. Lancet. 2011;377:2181\u201392.","journal-title":"Lancet"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0847-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0847-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T16:47:21Z","timestamp":1646412441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0847-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0847-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}